Merck KGaA (ETR:MRK)
110.60
-0.05 (-0.05%)
Nov 20, 2025, 5:38 PM CET
Merck KGaA Revenue
Merck KGaA had revenue of 5.32B EUR in the quarter ending September 30, 2025, with 0.99% growth. This brings the company's revenue in the last twelve months to 21.27B, up 1.47% year-over-year. In the year 2024, Merck KGaA had annual revenue of 21.16B with 0.78% growth.
Revenue (ttm)
21.27B
Revenue Growth
+1.47%
P/S Ratio
2.26
Revenue / Employee
341.18K
Employees
59,020
Market Cap
48.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
| Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
| Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
| Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
| Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.18B |
Merck KGaA News
- 8 hours ago - Valo Health Partners with Merck KGaA in $3B AI Drug Discovery Deal - GuruFocus
- 9 hours ago - Merck KGaA inks $3B deal to discover Parkinson’s drugs using AI - Seeking Alpha
- 12 hours ago - Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal - Reuters
- 12 hours ago - Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson's Disease and Related Disorders - Business Wire
- 7 days ago - Merck KGaA (MKKGY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Merck KGaA 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 7 days ago - Merck KGaA (MKGAF) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amidst Market Challenges - GuruFocus
- 7 days ago - Q3 2025 Merck KGaA Earnings Call Transcript - GuruFocus